CRMD
CorMedix IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$581.81M
P/E Ratio
3.61
EPS
$2.04
Beta
1.41
52W High
$17.43
52W Low
$6.12
50-Day MA
$7.07
200-Day MA
$10.34
Dividend Yield
—
Profit Margin
52.30%
Forward P/E
11.51
PEG Ratio
0.00
About CorMedix Inc
CorMedix Inc., a biopharmaceutical company, focuses on developing and marketing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. The company is headquartered in Berkeley Heights, New Jersey.
Fundamentals
| Revenue (TTM) | $311.71M |
| Gross Profit (TTM) | $289.62M |
| EBITDA | $174.89M |
| Operating Margin | 53.90% |
| Return on Equity | 66.60% |
| Return on Assets | 21.20% |
| Revenue/Share (TTM) | $4.33 |
| Book Value | $5.11 |
| Price-to-Book | 1.41 |
| Price-to-Sales (TTM) | 1.87 |
| EV/Revenue | 1.84 |
| EV/EBITDA | 3.43 |
| Quarterly Earnings Growth (YoY) | -28.30% |
| Quarterly Revenue Growth (YoY) | 312.10% |
| Shares Outstanding | $79.05M |
| Float | $68.06M |
| % Insiders | 7.98% |
| % Institutions | 56.03% |
Historical Volatility
HV 10-Day
25.64%
HV 20-Day
30.20%
HV 30-Day
49.71%
HV 60-Day
49.78%
HV Rank
8.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($14.57 target)
3
Strong Buy4
BuyData last updated: 4/10/2026